For research use only
| Cat No. | ABC-TC0112 |
| Product Type | Human Lung Cancer Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Lung Adenocarinoma |
| Product Code | CaLu-6; CALU-6; Calu.6; Calu 6; Calu6; CALU6; CaLu-06 |
From anaplastic lung carcinoma, Calu-6 carries KRAS Q61K mutation, p53-null, S100A6-sensitive, ideal for DNA repair, renin regulation, and tumor modeling.
| Product Code | CaLu-6; CALU-6; Calu.6; Calu 6; Calu6; CALU6; CaLu-06 |
| Species | Human |
| Cat.No | ABC-TC0112 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Lung Adenocarinoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
The Calu-6 cell line can be utilized as a model to investigate tumor suppression factors and pathways for potential therapies. It has been instrumental in studying the antiproliferative mechanism of apoptosis and understanding the molecular mechanisms of cytotoxic drugs used in lung cancer treatment. Additionally, Calu-6 contributes to the development of novel agents that target specific intracellular pathways associated with cancer cell properties, aiding the ongoing efforts in developing effective treatments for lung cancer and other types of cancer.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
